{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:00:58Z","timestamp":1795064458735,"version":"4.10.2"},"reference-count":135,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["15\u20132-404"],"award-info":[{"award-number":["15\u20132-404"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["19\u20131-204"],"award-info":[{"award-number":["19\u20131-204"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Joint inflammation is present in the majority of OA patients and pro-inflammatory mediators, such as IL-6, are actively involved in disease progression. Increased levels of IL-6 in serum or synovial fluid from OA patients correlate with disease incidence and severity, with IL-6 playing a pivotal role in the development of cartilage pathology, e.g. via induction of matrix-degrading enzymes. However, IL-6 also increases expression of anti-catabolic factors, suggesting a protective role. Until now, this dual role of IL-6 is incompletely understood and may be caused by differential effects of IL-6 classic vs trans-signalling. Here, we review current evidence regarding the role of IL-6 classic- and trans-signalling in local joint pathology of cartilage, synovium and bone. Furthermore, we discuss targeting of IL-6 in experimental OA models and provide future perspective for OA treatment by evaluating currently available IL-6 targeting strategies.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa248","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T07:10:48Z","timestamp":1587366648000},"page":"2681-2694","source":"Crossref","is-referenced-by-count":180,"title":["A roadmap to target interleukin-6 in osteoarthritis"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-5386","authenticated-orcid":false,"given":"Renske","family":"Wiegertjes","sequence":"first","affiliation":[{"name":"Department of Experimental Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fons A J","family":"van de Loo","sequence":"additional","affiliation":[{"name":"Department of Experimental Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-0313","authenticated-orcid":false,"given":"Esmeralda N","family":"Blaney Davidson","sequence":"additional","affiliation":[{"name":"Department of Experimental Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2020092423555344900_keaa248-B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2005.09.007","article-title":"Osteoarthritis: epidemiology","volume":"20","author":"Arden","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020092423555344900_keaa248-B2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2014.01.004","article-title":"The epidemiology of osteoarthritis","volume":"28","author":"Johnson","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020092423555344900_keaa248-B3","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2020092423555344900_keaa248-B5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","article-title":"Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis \u2013 results of a 1 year longitudinal arthroscopic study in 422 patients","volume":"13","author":"Ayral","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A phase II trial of lutikizumab, an anti-interleukin-1alpha\/beta dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555344900_keaa248-B9","first-page":"1323","article-title":"A pilot study of tumor necrosis factor inhibition in erosive\/inflammatory osteoarthritis of the hands","volume":"34","author":"Magnano","year":"2007","journal-title":"J Rheumatol"},{"key":"2020092423555344900_keaa248-B10","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/ar4044","article-title":"Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee","volume":"14","author":"Maksymowych","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2020092423555344900_keaa248-B11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"key":"2020092423555344900_keaa248-B12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: a paradigm for cytokines","volume":"258","author":"Kishimoto","year":"1992","journal-title":"Science"},{"key":"2020092423555344900_keaa248-B13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","article-title":"Interleukin-6 and its receptors: a highly regulated and dynamic system","volume":"70","author":"Wolf","year":"2014","journal-title":"Cytokine"},{"key":"2020092423555344900_keaa248-B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2012.04.001","article-title":"Plasticity and cross-talk of interleukin 6-type cytokines","volume":"23","author":"Garbers","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"2020092423555344900_keaa248-B15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","article-title":"Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms","volume":"7","author":"Luo","year":"2016","journal-title":"Front Immunol"},{"key":"2020092423555344900_keaa248-B16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/43219","article-title":"Structure and function of a new STAT-induced STAT inhibitor","volume":"387","author":"Naka","year":"1997","journal-title":"Nature"},{"key":"2020092423555344900_keaa248-B17","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1073\/pnas.95.18.10626","article-title":"Inhibition of Stat1-mediated gene activation by PIAS1","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020092423555344900_keaa248-B18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.smim.2013.12.004","article-title":"Inhibition of IL-6 family cytokines by SOCS3","volume":"26","author":"Babon","year":"2014","journal-title":"Semin Immunol"},{"key":"2020092423555344900_keaa248-B19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat Immunol"},{"key":"2020092423555344900_keaa248-B20","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1074\/jbc.M210044200","article-title":"Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF","volume":"278","author":"Schuster","year":"2003","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B21","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.0901464","article-title":"The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling","volume":"183","author":"Crabe","year":"2009","journal-title":"J Immunol"},{"key":"2020092423555344900_keaa248-B22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1242\/jcs.065326","article-title":"Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation","volume":"123","author":"Radtke","year":"2010","journal-title":"J Cell Sci"},{"key":"2020092423555344900_keaa248-B23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1189\/jlb.72.1.154","article-title":"Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis","volume":"72","author":"Ahmed","year":"2002","journal-title":"J Leukoc Biol"},{"key":"2020092423555344900_keaa248-B24","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1074\/jbc.M413284200","article-title":"Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.joca.2019.04.014","article-title":"TGF-beta dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression","volume":"27","author":"Wiegertjes","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/abbs\/gmx118","article-title":"Smad3-STAT3 crosstalk in pathophysiological contexts","volume":"50","author":"Itoh","year":"2018","journal-title":"Acta Biochim Biophys Sin"},{"key":"2020092423555344900_keaa248-B27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cpt.782","article-title":"The soluble interleukin 6 receptor: advanced therapeutic options in inflammation","volume":"102","author":"Rose-John","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2020092423555344900_keaa248-B28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/1043-4666(92)90043-Q","article-title":"Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor","volume":"4","author":"Lust","year":"1992","journal-title":"Cytokine"},{"key":"2020092423555344900_keaa248-B29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"M\u00fclberg","year":"1993","journal-title":"Eur J Immunol"},{"key":"2020092423555344900_keaa248-B30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.183.4.1399","article-title":"The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6","volume":"183","author":"Peters","year":"1996","journal-title":"J Exp Med"},{"key":"2020092423555344900_keaa248-B31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2020092423555344900_keaa248-B32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12964-019-0356-0","article-title":"Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor alpha to gp130 expression: fusing experimental insights and dynamic modelling","volume":"17","author":"Reeh","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2020092423555344900_keaa248-B33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"key":"2020092423555344900_keaa248-B34","doi-asserted-by":"crossref","first-page":"42959","DOI":"10.1074\/jbc.M111.295758","article-title":"Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor","volume":"286","author":"Garbers","year":"2011","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur J Biochem"},{"key":"2020092423555344900_keaa248-B36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","article-title":"Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"key":"2020092423555344900_keaa248-B37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni.3632","article-title":"Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells","volume":"18","author":"Heink","year":"2017","journal-title":"Nat Immunol"},{"key":"2020092423555344900_keaa248-B38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","article-title":"Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides","volume":"31","author":"Houssiau","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","article-title":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation","volume":"11","author":"Kotake","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2020092423555344900_keaa248-B40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.joca.2013.04.002","article-title":"An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid","volume":"21","author":"Beekhuizen","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B41","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar3555","article-title":"Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via toll-like receptor 4","volume":"14","author":"Sohn","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2020092423555344900_keaa248-B42","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.12998\/wjcc.v7.i11.1262","article-title":"Elevated levels of interleukin-1beta, interleukin-6, tumor necrosis factor-alpha and vascular endothelial growth factor in patients with knee articular cartilage injury","volume":"7","author":"Wang","year":"2019","journal-title":"World J Clin Cases"},{"key":"2020092423555344900_keaa248-B43","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.24598","article-title":"Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study","volume":"60","author":"Livshits","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.joca.2010.08.016","article-title":"Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults","volume":"18","author":"Stannus","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.joca.2010.03.016","article-title":"Low innate production of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age","volume":"18","author":"Goekoop","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B46","first-page":"128","article-title":"Comparison of synovial fluid cytokine levels between traumatic knee injury and end-stage osteoarthritis","volume":"30","author":"Siqueira","year":"2016","journal-title":"J\u00a0Knee Surg"},{"key":"2020092423555344900_keaa248-B47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.arthro.2015.08.033","article-title":"Correlation of synovial fluid biomarkers with cartilage pathology and associated outcomes in knee arthroscopy","volume":"32","author":"Cuellar","year":"2016","journal-title":"Arthroscopy"},{"key":"2020092423555344900_keaa248-B48","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.joca.2015.05.035","article-title":"Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy","volume":"23","author":"Larsson","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B49","doi-asserted-by":"crossref","first-page":"R262","DOI":"10.1186\/ar4107","article-title":"Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model","volume":"14","author":"Tsuchida","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2020092423555344900_keaa248-B50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13075-014-0441-0","article-title":"Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes","volume":"16","author":"Tsuchida","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2020092423555344900_keaa248-B51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/molecules24010109","article-title":"IL-6 in osteoarthritis: effects of pine stilbenoids","volume":"24","author":"Laavola","year":"2018","journal-title":"Molecules"},{"key":"2020092423555344900_keaa248-B52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/03009740701250785","article-title":"Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells","volume":"36","author":"Do\u00df","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"2020092423555344900_keaa248-B53","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1136\/ard.2005.037994","article-title":"EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis","volume":"64","author":"D\u2019Agostino","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI113921","article-title":"Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis","volume":"83","author":"Guerne","year":"1989","journal-title":"J Clin Invest"},{"key":"2020092423555344900_keaa248-B55","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2099","article-title":"The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis","volume":"8","author":"Bondeson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2020092423555344900_keaa248-B56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2017.01.004","article-title":"Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators","volume":"46","author":"Nguyen","year":"2017","journal-title":"Immunity"},{"key":"2020092423555344900_keaa248-B57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.joca.2010.03.014","article-title":"The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review","volume":"18","author":"Clockaerts","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B58","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1002\/art.24881","article-title":"The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor","volume":"60","author":"Distel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.joca.2016.09.001","article-title":"Infrapatellar fat pad aggravates degeneration of acute traumatized cartilage: a possible role for interleukin-6","volume":"25","author":"He","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B60","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/s41598-017-03759-w","article-title":"IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity","volume":"7","author":"Pearson","year":"2017","journal-title":"Sci Rep"},{"key":"2020092423555344900_keaa248-B61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00281-019-00747-2","article-title":"The role of interleukin-6 in glucose homeostasis and lipid metabolism","volume":"41","author":"Lehrskov","year":"2019","journal-title":"Semin Immunopathol"},{"key":"2020092423555344900_keaa248-B62","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2020092423555344900_keaa248-B63","first-page":"1510","article-title":"Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid","volume":"24","author":"Desgeorges","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"2020092423555344900_keaa248-B64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/BF03041306","article-title":"Synovial fluid and serum levels of soluble interleukin-6 receptor in patients with rheumatoid arthritis","volume":"8","author":"Fujikawa","year":"1998","journal-title":"Jpn J Rheumatol"},{"key":"2020092423555344900_keaa248-B65","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/art.21818","article-title":"Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis","volume":"54","author":"Richards","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI7479","article-title":"Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis","volume":"106","author":"Tanaka","year":"2000","journal-title":"J Clin Invest"},{"key":"2020092423555344900_keaa248-B67","doi-asserted-by":"crossref","first-page":"13625","DOI":"10.1074\/jbc.273.22.13625","article-title":"Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity","volume":"273","author":"Silacci","year":"1998","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B68","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0021-9258(18)52202-X","article-title":"Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1\/erythroid potentiating activity (TIMP-1\/EPA)","volume":"266","author":"Lotz","year":"1991","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B69","first-page":"314","article-title":"Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose","volume":"21","author":"Malfait","year":"1994","journal-title":"J Rheumatol"},{"key":"2020092423555344900_keaa248-B70","first-page":"953","article-title":"Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes","volume":"17","author":"Kandel","year":"1990","journal-title":"J Rheumatol"},{"key":"2020092423555344900_keaa248-B71","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/art.1780331113","article-title":"Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage","volume":"33","author":"Nietfeld","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0945-053X(99)00021-9","article-title":"Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone","volume":"18","author":"Guerne","year":"1999","journal-title":"Matrix Biol"},{"key":"2020092423555344900_keaa248-B73","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/cbir.1998.0304","article-title":"Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures","volume":"22","author":"Jikko","year":"1998","journal-title":"Cell Biol Int"},{"key":"2020092423555344900_keaa248-B74","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1074\/jbc.M706387200","article-title":"Interleukin-6 (IL-6) and\/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter","volume":"283","author":"Poree","year":"2008","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B75","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.30451","article-title":"Interleukin-6 plays an essential role in hypoxia-inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice","volume":"63","author":"Ryu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B76","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.joca.2013.08.010","article-title":"Interleukin 6 mediates selected effects of Notch in chondrocytes","volume":"21","author":"Zanotti","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12891-019-2566-4","article-title":"Continuous low-intensity ultrasound attenuates IL-6 and TNFalpha-induced catabolic effects and repairs chondral fissures in bovine osteochondral explants","volume":"20","author":"Sahu","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"2020092423555344900_keaa248-B78","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/annrheumdis-2015-207487","article-title":"Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis","volume":"75","author":"Nasi","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B79","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.joca.2007.10.009","article-title":"Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation","volume":"16","author":"Mathy-Hartert","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B80","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/art.21752","article-title":"A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor","volume":"54","author":"Smeets","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/10520295.2017.1278792","article-title":"Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation","volume":"92","author":"Gui","year":"2017","journal-title":"Biotech Histochem"},{"key":"2020092423555344900_keaa248-B82","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.38701","article-title":"Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis","volume":"66","author":"Liu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555344900_keaa248-B83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(89)80008-0","article-title":"Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes","volume":"249","author":"Bauer","year":"1989","journal-title":"FEBS Lett"},{"key":"2020092423555344900_keaa248-B84","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B","article-title":"Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown","volume":"44","author":"Rowan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B85","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1002\/art.24857","article-title":"Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage","volume":"60","author":"Sui","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B86","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.joca.2014.04.024","article-title":"Physiological and excessive mechanical compression of articular cartilage activates Smad2\/3P signaling","volume":"22","author":"Madej","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B87","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.joca.2013.08.021","article-title":"Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-alpha and interleukin-6, but accentuates degradation above a strain threshold","volume":"21","author":"Li","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0945-053X(00)00111-6","article-title":"IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage","volume":"19","author":"Flannery","year":"2000","journal-title":"Matrix Biol"},{"key":"2020092423555344900_keaa248-B89","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1074\/jbc.M110773200","article-title":"JAK\/STAT but not ERK1\/ERK2 pathway mediates interleukin (IL)-6\/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression","volume":"278","author":"Legendre","year":"2003","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B90","first-page":"1307","article-title":"Role of interleukin 6 (IL-6)\/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase\/extracellular","volume":"32","author":"Legendre","year":"2005","journal-title":"J Rheumatol"},{"key":"2020092423555344900_keaa248-B91","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/art.1780351012","article-title":"Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts","volume":"35","author":"Ito","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2020092423555344900_keaa248-B92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1756-185X.2011.01656.x","article-title":"Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"15","author":"Mimata","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"2020092423555344900_keaa248-B93","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","article-title":"Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor","volume":"34","author":"Mihara","year":"1995","journal-title":"Br J Rheumatol"},{"key":"2020092423555344900_keaa248-B94","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020092423555344900_keaa248-B95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2008.11.004","article-title":"The dual role of IL-6-type cytokines on bone remodeling and bone tumors","volume":"20","author":"Blanchard","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"2020092423555344900_keaa248-B96","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1074\/jbc.RA119.008074","article-title":"IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis","volume":"294","author":"McGregor","year":"2019","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B97","doi-asserted-by":"crossref","first-page":"41411","DOI":"10.1038\/srep41411","article-title":"Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-kappaB, ERK and JNK signaling pathways","volume":"7","author":"Feng","year":"2017","journal-title":"Sci Rep"},{"key":"2020092423555344900_keaa248-B98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fphys.2018.00409","article-title":"Mediators and patterns of muscle loss in chronic systemic inflammation","volume":"9","author":"Perez-Baos","year":"2018","journal-title":"Front Physiol"},{"key":"2020092423555344900_keaa248-B99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drudis.2013.08.004","article-title":"Bearing arms against osteoarthritis and sarcopenia: when cartilage and skeletal muscle find common interest in talking together","volume":"19","author":"De Ceuninck","year":"2014","journal-title":"Drug Discov Today"},{"key":"2020092423555344900_keaa248-B100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.archger.2010.05.009","article-title":"Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA)","volume":"52","author":"Santos","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"2020092423555344900_keaa248-B101","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/acr.20625","article-title":"Association between skeletal muscle inflammatory markers and walking pattern in people with knee osteoarthritis","volume":"63","author":"Levinger","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2020092423555344900_keaa248-B102","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1111\/febs.12338","article-title":"Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?","volume":"280","author":"Munoz-Canoves","year":"2013","journal-title":"FEBS J"},{"key":"2020092423555344900_keaa248-B103","first-page":"1143","article-title":"Interleukin-6 from subchondral bone mesenchymal stem cells contributes to the pathological phenotypes of experimental osteoarthritis","volume":"10","author":"Wu","year":"2018","journal-title":"Am J Transl Res"},{"key":"2020092423555344900_keaa248-B104","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0002-9440(10)64634-2","article-title":"Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo","volume":"157","author":"Langdon","year":"2000","journal-title":"Am J Pathol"},{"key":"2020092423555344900_keaa248-B105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/annrheumdis-2016-209757","article-title":"Systemic inhibition of IL-6\/Stat3 signalling protects against experimental osteoarthritis","volume":"76","author":"Latourte","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B106","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.joca.2018.10.010","article-title":"IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice","volume":"27","author":"Kamiya","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B107","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.joca.2015.01.008","article-title":"Aging-related inflammation in osteoarthritis","volume":"23","author":"Greene","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B108","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: a magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020092423555344900_keaa248-B109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.joca.2004.09.011","article-title":"Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging","volume":"13","author":"de Hooge","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B110","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI117995","article-title":"Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor","volume":"95","author":"Bellido","year":"1995","journal-title":"J Clin Invest"},{"key":"2020092423555344900_keaa248-B111","doi-asserted-by":"crossref","first-page":"31839","DOI":"10.1074\/jbc.M105185200","article-title":"Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"2020092423555344900_keaa248-B112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjc.6690394","article-title":"Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma","volume":"80","author":"Fontanini","year":"1999","journal-title":"Br J Cancer"},{"key":"2020092423555344900_keaa248-B113","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.joca.2015.05.011","article-title":"Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by suppressor of cytokine signaling-3","volume":"23","author":"Liu","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B114","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)61120-0","article-title":"Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand","volume":"160","author":"de Hooge","year":"2002","journal-title":"Am J Pathol"},{"key":"2020092423555344900_keaa248-B115","doi-asserted-by":"crossref","first-page":"e1006610","DOI":"10.1371\/journal.pgen.1006610","article-title":"Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes","volume":"13","author":"Hall","year":"2017","journal-title":"PLoS Genet"},{"key":"2020092423555344900_keaa248-B116","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1359\/JBMR.050209","article-title":"Interleukin-11 receptor signaling is required for normal bone remodeling","volume":"20","author":"Sims","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2020092423555344900_keaa248-B117","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/dev.121.5.1283","article-title":"Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death","volume":"121","author":"Ware","year":"1995","journal-title":"Development"},{"key":"2020092423555344900_keaa248-B118","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/annrheumdis-2017-212037","article-title":"Drug-induced modulation of gp130 signalling prevents articular cartilage degeneration and promotes repair","volume":"77","author":"Shkhyan","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"2020092423555344900_keaa248-B120","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/rheumatology\/key232","article-title":"Functional analysis of synovial fluid from osteoarthritic knee and carpometacarpal joints unravels different molecular profiles","volume":"58","author":"Barreto","year":"2019","journal-title":"Rheumatology"},{"key":"2020092423555344900_keaa248-B121","first-page":"146","article-title":"Soluble mediators in posttraumatic wrist and primary knee osteoarthritis","volume":"2","author":"Teunis","year":"2014","journal-title":"Arch Bone Jt Surg"},{"key":"2020092423555344900_keaa248-B122","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/BOR.0000000000000353","article-title":"Role of low-grade inflammation in osteoarthritis","volume":"29","author":"Scanzello","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2020092423555344900_keaa248-B123","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/annrheumdis-2015-209036","article-title":"Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis","volume":"76","author":"Damman","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B124","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.joca.2015.11.014","article-title":"Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype?","volume":"24","author":"Haugen","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B125","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/annrheumdis-2014-205348","article-title":"Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial","volume":"74","author":"Chevalier","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4085\/1062-6050-51.5.08","article-title":"Epidemiology of posttraumatic osteoarthritis","volume":"52","author":"Thomas","year":"2017","journal-title":"J Athl Train"},{"key":"2020092423555344900_keaa248-B127","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.39146","article-title":"Changes in cytokines and aggrecan ARGS neoepitope in synovial fluid and serum and in C-terminal crosslinking telopeptide of type II collagen and n-terminal crosslinking telopeptide of type I collagen in urine over five years after anterior cruciate ligament rupture: an exploratory analysis in the knee anterior cruciate ligament, nonsurgical versus surgical treatment trial","volume":"67","author":"Struglics","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555344900_keaa248-B128","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.39677","article-title":"Acute molecular changes in synovial fluid following human knee injury: association with early clinical outcomes","volume":"68","author":"Watt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555344900_keaa248-B129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2020092423555344900_keaa248-B130","doi-asserted-by":"crossref","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O'Shea","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020092423555344900_keaa248-B131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bcp.2018.07.034","article-title":"Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo","volume":"165","author":"Kjelgaard-Petersen","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2020092423555344900_keaa248-B132","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.joca.2018.05.005","article-title":"IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis","volume":"26","author":"Steen-Louws","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B133","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.joca.2016.09.010","article-title":"The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits","volume":"25","author":"Zhang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"2020092423555344900_keaa248-B134","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.intimp.2005.05.010","article-title":"Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family","volume":"5","author":"Mihara","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"2020092423555344900_keaa248-B135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2681\/33790424\/keaa248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2681\/33790424\/keaa248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T16:16:19Z","timestamp":1666368979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2681\/5874133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":135,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa248","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,21]]}}}